Clinical Trial Update: Safety Study of 90Y-hMN14 to Treat Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

A safety study of 90Y-hMN14 for pancreatic cancer across Phase 1 and Phase 2 has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Neoplasms

Drugs mentioned

• 90Y-hMN14 (90Y-hMN14)

Snippet

Sponsor: Gilead Sciences | Conditions: Pancreatic Neoplasms | Phase 1, Phase 2 | Status: COMPLETED